Healthcare Services

Clinical Trial Imaging Market Expanding with Increasing Chronic Disease Cases

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Clinical Trial Imaging Market Grow Between 2026 And 2030?

The clinical trial imaging market size has shown significant growth over recent years. It is anticipated to increase from $1.58 billion in 2025 to $1.72 billion in 2026, at a compound annual growth rate (CAGR) of 9.3%. The market’s historical expansion was driven by factors such as the increasing complexity of clinical trial protocols, the growing use of imaging endpoints in oncology trials, the global expansion of clinical trials, a rising regulatory emphasis on imaging accuracy, and the availability of advanced imaging modalities.

The clinical trial imaging market is projected to experience robust expansion over the coming years. This market is set to reach $2.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. The anticipated growth during this period stems from factors such as the greater acceptance of decentralized clinical trials, increased investments in AI-enabled imaging platforms, a rising need for real-time imaging analytics, the broadening scope of precision medicine trials, and enhanced integration of imaging with clinical data platforms. Key trends anticipated for the forecast period encompass a greater uptake of AI-assisted image analysis, the growing application of multi-modality imaging in trials, an increasing demand for centralized image management services, the expansion of remote imaging review capabilities, and a heightened emphasis on imaging standardization and quality control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

What Significant Factors Are Influencing The Clinical Trial Imaging Market Expansion?

The future expansion of the clinical trial imaging market is anticipated to be driven by the rising occurrence of chronic diseases. A chronic disease refers to a persistent health issue often demanding continuous medical care, which may restrict an individual’s daily functions or overall quality of life. The heightened incidence of these chronic conditions stems from factors such as exposure to environmental pollutants like air pollution, chemicals, and toxins, evolving lifestyle habits, and inherited genetic predispositions. Clinical trial imaging facilitates effective oversight by offering visual insights that aid patients in comprehending their health status and the efficacy of therapeutic interventions, thereby enhancing treatment compliance and patient contentment. As an illustration, data from January 2023, published by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, indicates a projection that by 2050, the population of those aged 50 years and above suffering from at least one chronic illness will increase dramatically by 99.5%, growing from 71.522 million in 2020 to reach 142.66 million. Consequently, the growing occurrence of chronic diseases serves as a primary impetus for the clinical trial imaging market.

How Is Segmentation Applied In The Clinical Trial Imaging Market Segment Analysis?

The clinical trial imaging market covered in this report is segmented –

1) By Product And Services: Services, Software

2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Other Modalities

3) By Application: Oncology, Neurology, Cardiology, Endocrinology, Dermatology, Hematology, Other Applications

4) By End User: Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Medical Device Manufacturers, Academic And Government Research Institutes, Other End-Users

Subsegments:

1) By Services: Imaging Services For Diagnostics, Image Acquisition Services, Image Analysis Services, Image Management And Archiving Services

2) By Software: Imaging Software For Analysis, Image Processing Software, Radiology Information Systems (RIS), Picture Archiving And Communication Systems (PACS)

What Trends Are Affecting The Direction Of The Clinical Trial Imaging Market?

Leading companies within the clinical trial imaging market are actively developing cloud-based image instruments to deliver superior solutions and enhance the overall efficiency of clinical trials. These cloud-based imaging tools are essentially software applications and platforms that harness cloud computing technology for the storage, management, and analysis of medical images. For example, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, unveiled an advanced cloud-based image viewer tool. This groundbreaking tool enables real-time, on-demand viewing and manipulation of high-resolution images, granting read-quality access to images almost instantly while simultaneously doing away with formerly required manual steps. It significantly optimizes the image viewing procedure, eradicating manual efforts and ensuring image accessibility is easy, secure, and compliant with data privacy regulations. The tool provides full-resolution viewing and manipulation functionalities, empowering end users to extract meaningful insights from their trial subjects.

Who Are The Companies Participating In The Clinical Trial Imaging Market Environment?

Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, ICON Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solutions Inc., Biotelemetry Inc., ProScan Imaging LLC, Invicro LLC, Perspectum, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

Get The Full Clinical Trial Imaging Market Report:

https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

Which Region Holds The Highest Market Share In The Clinical Trial Imaging Market?

North America was the largest region in the clinical trial imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Clinical Trial Imaging Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

Browse Through More Reports Similar to the Global Clinical Trial Imaging Market 2026, By The Business Research Company

Vascular Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report

Medical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

Preclinical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795